Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022
Point-of-Care testing can be defined as the medical diagnostic testing performed outside the clinical laboratory near to the place where the patient is receiving treatment. This type of testing is performed by non-laboratory personnel and the results are used for clinical decision making. The Point-of-Care tests have immense potential to improve global health, and to eventually reduce public and national spending on health.
The Point-of-Care testing devices have now found applications in a large number of medical conditions. Due to its increased usage in the field of critical care settings to deliver decentralized, patient-centric healthcare to the patients, the projections for the global Point-of-Care testing market is expected to witness a rapid growth. It is predicted that by 2022, the global Point-of-Care testing market will reach U$$ 30 Billion.
As per RNCOS report “Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022”, the global Point-of-Care testing market is anticipated to witness a rapid growth during 2017-2022. This report provides a detailed analysis of the current and future market scenario of the global Point-of-Care testing market with a brief outlook of the IVD industry. The report provides insight about the major drivers, such as increasing awareness about POCT, technological advancements, increasing FDA approvals, for the global Point-of-Care testing market.
Furthermore, few challenges, such as product recalls and lack of regulatory standards, hindering the growth of the global Point-of-Care testing market have also been mentioned in the report. In addition, the report also highlights various opportunities available for growth of the global Point-of-Care testing market. Various trends and developments in the industry have also been cited in the report.
The global Point-of-Care testing market has been segmented on the basis of type of product. The major types of Point-of-Care testing present in the market include glucose monitoring kits, blood gas and electrolyte analysers, pregnancy & fertility testing kits, cardiac markers, infectious diseases testing kits, coagulation monitoring kits and drug-of-abuse testing kits amongst others. According to the report, glucose monitoring kits accounted for the largest share in 2017 due to rising prevalence of diabetes & technological advancements in self-monitoring of blood glucose. Based on geography, the report divides the market into North America, Europe, Asia-Pacific, and Rest of the World. In 2017, North America accounted for the largest share.
The last section of the report discusses about the prominent players in global Point-of-Care testing market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios. The recent developments of every player have also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Point-of-Care testing market.
The Point-of-Care testing devices have now found applications in a large number of medical conditions. Due to its increased usage in the field of critical care settings to deliver decentralized, patient-centric healthcare to the patients, the projections for the global Point-of-Care testing market is expected to witness a rapid growth. It is predicted that by 2022, the global Point-of-Care testing market will reach U$$ 30 Billion.
As per RNCOS report “Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022”, the global Point-of-Care testing market is anticipated to witness a rapid growth during 2017-2022. This report provides a detailed analysis of the current and future market scenario of the global Point-of-Care testing market with a brief outlook of the IVD industry. The report provides insight about the major drivers, such as increasing awareness about POCT, technological advancements, increasing FDA approvals, for the global Point-of-Care testing market.
Furthermore, few challenges, such as product recalls and lack of regulatory standards, hindering the growth of the global Point-of-Care testing market have also been mentioned in the report. In addition, the report also highlights various opportunities available for growth of the global Point-of-Care testing market. Various trends and developments in the industry have also been cited in the report.
The global Point-of-Care testing market has been segmented on the basis of type of product. The major types of Point-of-Care testing present in the market include glucose monitoring kits, blood gas and electrolyte analysers, pregnancy & fertility testing kits, cardiac markers, infectious diseases testing kits, coagulation monitoring kits and drug-of-abuse testing kits amongst others. According to the report, glucose monitoring kits accounted for the largest share in 2017 due to rising prevalence of diabetes & technological advancements in self-monitoring of blood glucose. Based on geography, the report divides the market into North America, Europe, Asia-Pacific, and Rest of the World. In 2017, North America accounted for the largest share.
The last section of the report discusses about the prominent players in global Point-of-Care testing market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios. The recent developments of every player have also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Point-of-Care testing market.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. IN VITRO DIAGNOSTIC MARKET OVERVIEW
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. POINT-OF-CARE DIAGNOSTICS: AN OVERVIEW
5. MARKET DYNAMICS
5.1 Market Drivers
5.1.1 High Prevalence of Infectious and Lifestyle Related Diseases
5.1.2 Rising Use of Home Based Point-of-Care Diagnostics
5.1.3 Government Initiatives
5.1.4 Technological Advancements
5.1.5 Rising FDA Approvals
5.1.6 Lack of Skilled Lab Personnel
5.1.7 Rising Awareness about POCT
5.2 Market Restraints
5.2.1 Product Recalls
5.2.2 Lack of Regulatory Standards
5.2.3 Data Management & Connectivity
5.3 Market Opportunities
5.3.1 Physical Robotic Telepresence
5.3.2 Smart Virtual Assistant in Association with Mobile Devices
6. POINT-OF-CARE TESTING MARKET OUTLOOK 2022
7. POINT-OF-CARE TESTING MARKET, BY PRODUCT
7.1 Introduction
7.1.1 Glucose Monitoring Kits
7.1.2 Blood Gas and Electrolyte Analyzers
7.1.3 Pregnancy & Fertility Testing Kits
7.1.4 Cardiac Markers
7.1.5 Infectious Diseases Testing Kits
7.1.6 Drug-of-Abuse Testing Kits
7.1.7 Others
8. POINT-OF-CARE TESTING MARKET, BY REGION
8.1 Introduction
8.1.1 North America
8.1.2 Europe
8.1.3 Asia Pacific
8.1.4 Rest of the World
9. INDUSTRY TRENDS AND DEVELOPMENTS
9.1 Portable Ultrasound Providing Care on Site
9.2 Microfluidics Technology Crowding the POCT Industry
10. COMPANY PROFILES
10.1 Becton, Dickinson and Company
10.2 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
10.3 Siemens Healthineers
10.4 Danaher Corporation
10.5 Abbott Laboratories
10.6 Johnson & Johnson
10.7 OraSure Technologies, Inc.
10.8 Thermo Fisher Scientific Inc.
10.9 Medtronic plc
2. RESEARCH METHODOLOGY
3. IN VITRO DIAGNOSTIC MARKET OVERVIEW
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. POINT-OF-CARE DIAGNOSTICS: AN OVERVIEW
5. MARKET DYNAMICS
5.1 Market Drivers
5.1.1 High Prevalence of Infectious and Lifestyle Related Diseases
5.1.2 Rising Use of Home Based Point-of-Care Diagnostics
5.1.3 Government Initiatives
5.1.4 Technological Advancements
5.1.5 Rising FDA Approvals
5.1.6 Lack of Skilled Lab Personnel
5.1.7 Rising Awareness about POCT
5.2 Market Restraints
5.2.1 Product Recalls
5.2.2 Lack of Regulatory Standards
5.2.3 Data Management & Connectivity
5.3 Market Opportunities
5.3.1 Physical Robotic Telepresence
5.3.2 Smart Virtual Assistant in Association with Mobile Devices
6. POINT-OF-CARE TESTING MARKET OUTLOOK 2022
7. POINT-OF-CARE TESTING MARKET, BY PRODUCT
7.1 Introduction
7.1.1 Glucose Monitoring Kits
7.1.2 Blood Gas and Electrolyte Analyzers
7.1.3 Pregnancy & Fertility Testing Kits
7.1.4 Cardiac Markers
7.1.5 Infectious Diseases Testing Kits
7.1.6 Drug-of-Abuse Testing Kits
7.1.7 Others
8. POINT-OF-CARE TESTING MARKET, BY REGION
8.1 Introduction
8.1.1 North America
8.1.2 Europe
8.1.3 Asia Pacific
8.1.4 Rest of the World
9. INDUSTRY TRENDS AND DEVELOPMENTS
9.1 Portable Ultrasound Providing Care on Site
9.2 Microfluidics Technology Crowding the POCT Industry
10. COMPANY PROFILES
10.1 Becton, Dickinson and Company
10.2 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
10.3 Siemens Healthineers
10.4 Danaher Corporation
10.5 Abbott Laboratories
10.6 Johnson & Johnson
10.7 OraSure Technologies, Inc.
10.8 Thermo Fisher Scientific Inc.
10.9 Medtronic plc
LIST OF FIGURES:
Figure 3-1: Global - Diabetes Incidence (Million), 2015 & 2040
Figure 3-2: Global - In Vitro Diagnostic Market (Billion US$), 2017-2022
Figure 6-1: Global - Share of Point-of-Care Testing in the IVD Market (%), 2017
Figure 6-2: Global - Share of Point-of-Care Testing in the IVD Market (%), 2022
Figure 6-3: Global - Point-of-Care Testing Market (Billion US$), 2017-2022
Figure 7-1: Global - Point-of-Care Testing Market by Product (%), 2017
Figure 7-2: Global - Point-of-Care Testing Market by Product (%), 2022
Figure 7-3: Global - Glucose Monitoring Kits Market (Billion US$), 2017-2022
Figure 7-4: Global - Blood Gas and Electrolyte Analyzers Market (Billion US$), 2017-2022
Figure 7-5: Global - Pregnancy & Fertility Testing Kits Market (Billion US$), 2017-2022
Figure 7-6: Global - Cardiac Markers Market (Billion US$), 2017-2022
Figure 7-7: Global - Infectious Diseases Testing Kits Market (Billion US$), 2017-2022
Figure 7-8: Global - Drug-of-Abuse Testing Kits Market (Billion US$), 2017-2022
Figure 7-9: Global - Other POC Testing Kits Market (Billion US$), 2017-2022
Figure 8-1: Global - Point-of-Care Testing Market by Region (%), 2017
Figure 8-2: Global - Point-of-Care Testing Market by Region (%), 2022
Figure 8-3: North America - Point-of-Care Testing Market (Billion US$), 2017-2022
Figure 8-4: Europe - Point-of-Care Testing Market (Billion US$), 2017-2022
Figure 8-5: Asia Pacific - Point-of-Care Testing Market (Billion US$), 2017-2022
Figure 8-6: Rest of the World - Point-of-Care Testing Market (Billion US$), 2017-2022
Figure 10-1: Becton, Dickinson and Company - Revenue by Segment (%), 2019
Figure 10-2: Becton, Dickinson and Company - Revenue by Geography (%), 2019
Figure 10-3: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Business Segment (%), 2019
Figure 10-4: F.Hoffmann-La Roche Ltd. - Revenue Breakup by Geography (%), 2019
Figure 10-5: Danaher Corporation - Breakup of Sales by Business Segments (%), 2019
Figure 10-6: Danaher Corporation - Breakup of Sales by Geography (%), 2019
Figure 10-7: Abbott Laboratories - Revenue Breakup by Segments (%), 2019
Figure 10-8: Abbott Laboratories - Revenue Breakup by Geography (%), 2019
Figure 10-9: Johnson & Johnson - Revenue by Segment (%), 2019
Figure 10-10: Johnson & Johnson - Medical Devices Revenue by Segment (%), 2019
Figure 10-11: Johnson & Johnson - Revenue by Geography (%), 2019
Figure 10-12: Johnson & Johnson - Medical Devices Revenue by Geography (%), 2019
Figure 10-13: OraSure Technologies, Inc. - Revenue by Segment (%), 2019
Figure 10-14: OraSure Technologies, Inc. - OSUR Revenue by Segment (%), 2019
Figure 10-15: OraSure Technologies, Inc. - Revenue by Geography (%), 2019
Figure 10-16: Thermo Fisher Scientific Inc. - Revenue Breakup by Segments (%), 2019
Figure 10-17: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2019
Figure 10-18: Medtronic plc - Breakup of Revenue by Business Segments (%), 2019
Figure 10-19: Medtronic plc - Breakup of Revenue by Geography (%), 2019
Figure 3-1: Global - Diabetes Incidence (Million), 2015 & 2040
Figure 3-2: Global - In Vitro Diagnostic Market (Billion US$), 2017-2022
Figure 6-1: Global - Share of Point-of-Care Testing in the IVD Market (%), 2017
Figure 6-2: Global - Share of Point-of-Care Testing in the IVD Market (%), 2022
Figure 6-3: Global - Point-of-Care Testing Market (Billion US$), 2017-2022
Figure 7-1: Global - Point-of-Care Testing Market by Product (%), 2017
Figure 7-2: Global - Point-of-Care Testing Market by Product (%), 2022
Figure 7-3: Global - Glucose Monitoring Kits Market (Billion US$), 2017-2022
Figure 7-4: Global - Blood Gas and Electrolyte Analyzers Market (Billion US$), 2017-2022
Figure 7-5: Global - Pregnancy & Fertility Testing Kits Market (Billion US$), 2017-2022
Figure 7-6: Global - Cardiac Markers Market (Billion US$), 2017-2022
Figure 7-7: Global - Infectious Diseases Testing Kits Market (Billion US$), 2017-2022
Figure 7-8: Global - Drug-of-Abuse Testing Kits Market (Billion US$), 2017-2022
Figure 7-9: Global - Other POC Testing Kits Market (Billion US$), 2017-2022
Figure 8-1: Global - Point-of-Care Testing Market by Region (%), 2017
Figure 8-2: Global - Point-of-Care Testing Market by Region (%), 2022
Figure 8-3: North America - Point-of-Care Testing Market (Billion US$), 2017-2022
Figure 8-4: Europe - Point-of-Care Testing Market (Billion US$), 2017-2022
Figure 8-5: Asia Pacific - Point-of-Care Testing Market (Billion US$), 2017-2022
Figure 8-6: Rest of the World - Point-of-Care Testing Market (Billion US$), 2017-2022
Figure 10-1: Becton, Dickinson and Company - Revenue by Segment (%), 2019
Figure 10-2: Becton, Dickinson and Company - Revenue by Geography (%), 2019
Figure 10-3: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Business Segment (%), 2019
Figure 10-4: F.Hoffmann-La Roche Ltd. - Revenue Breakup by Geography (%), 2019
Figure 10-5: Danaher Corporation - Breakup of Sales by Business Segments (%), 2019
Figure 10-6: Danaher Corporation - Breakup of Sales by Geography (%), 2019
Figure 10-7: Abbott Laboratories - Revenue Breakup by Segments (%), 2019
Figure 10-8: Abbott Laboratories - Revenue Breakup by Geography (%), 2019
Figure 10-9: Johnson & Johnson - Revenue by Segment (%), 2019
Figure 10-10: Johnson & Johnson - Medical Devices Revenue by Segment (%), 2019
Figure 10-11: Johnson & Johnson - Revenue by Geography (%), 2019
Figure 10-12: Johnson & Johnson - Medical Devices Revenue by Geography (%), 2019
Figure 10-13: OraSure Technologies, Inc. - Revenue by Segment (%), 2019
Figure 10-14: OraSure Technologies, Inc. - OSUR Revenue by Segment (%), 2019
Figure 10-15: OraSure Technologies, Inc. - Revenue by Geography (%), 2019
Figure 10-16: Thermo Fisher Scientific Inc. - Revenue Breakup by Segments (%), 2019
Figure 10-17: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2019
Figure 10-18: Medtronic plc - Breakup of Revenue by Business Segments (%), 2019
Figure 10-19: Medtronic plc - Breakup of Revenue by Geography (%), 2019
LIST OF TABLES:
Table 7-1: Frequently used Point-of-Care Glucose Monitoring Devices
Table 7-2: Differences between the Blood Gas Analyzer and Auto-Analyzer
Table 7-3: Home Pregnancy Test Kits
Table 10-1: Becton, Dickinson and Company - Key Financials (Million US$), 2017-2019
Table 10-2: Becton, Dickinson and Company - Product Portfolio for Point-of-Care Testing
Table 10-3: F. Hoffmann-La Roche Ltd. - Key Financials (Billion US$), 2017-2019
Table 10-4: Roche Diagnostics - Product Portfolio for Point-of-Care Testing
Table 10-5: Siemens Healthineers - Key Financials (Million US$), 2017-2019
Table 10-6: Siemens Healthineers - Product Portfolio for Point-of-Care Testing
Table 10-7: Danaher Corporation - Key Financials (Million US$), 2017-2019
Table 10-8: Danaher Corporation - Product Portfolio for Point-of-Care Testing
Table 10-9: Abbott Laboratories - Key Financials (Million US$), 2017-2019
Table 10-10: Abbott Laboratories - Product Portfolio for Point-of-Care Testing
Table 10-11: Johnson & Johnson - Key Financials (Million US$), 2017-2019
Table 10-12: Johnson & Johnson - Product Portfolio for Point-of-Care Testing
Table 10-13: OraSure Technologies, Inc. - Key Financials (Million US$), 2017-2019
Table 10-14: OraSure Technologies, Inc. - Product Portfolio for Point-of-Care Testing
Table 10-15: Thermo Fisher Scientific, Inc. - Key Financials (Million US$), 2017-2019
Table 10-16: Thermo Fisher Scientific Inc. - Product Portfolio for Point-of-Care Testing
Table 10-17: Medtronic plc - Key Financials (Billion US$), 2017-2019
Table 10-18: Medtronic plc - Product Portfolio for Point-of-Care Testing
Table 7-1: Frequently used Point-of-Care Glucose Monitoring Devices
Table 7-2: Differences between the Blood Gas Analyzer and Auto-Analyzer
Table 7-3: Home Pregnancy Test Kits
Table 10-1: Becton, Dickinson and Company - Key Financials (Million US$), 2017-2019
Table 10-2: Becton, Dickinson and Company - Product Portfolio for Point-of-Care Testing
Table 10-3: F. Hoffmann-La Roche Ltd. - Key Financials (Billion US$), 2017-2019
Table 10-4: Roche Diagnostics - Product Portfolio for Point-of-Care Testing
Table 10-5: Siemens Healthineers - Key Financials (Million US$), 2017-2019
Table 10-6: Siemens Healthineers - Product Portfolio for Point-of-Care Testing
Table 10-7: Danaher Corporation - Key Financials (Million US$), 2017-2019
Table 10-8: Danaher Corporation - Product Portfolio for Point-of-Care Testing
Table 10-9: Abbott Laboratories - Key Financials (Million US$), 2017-2019
Table 10-10: Abbott Laboratories - Product Portfolio for Point-of-Care Testing
Table 10-11: Johnson & Johnson - Key Financials (Million US$), 2017-2019
Table 10-12: Johnson & Johnson - Product Portfolio for Point-of-Care Testing
Table 10-13: OraSure Technologies, Inc. - Key Financials (Million US$), 2017-2019
Table 10-14: OraSure Technologies, Inc. - Product Portfolio for Point-of-Care Testing
Table 10-15: Thermo Fisher Scientific, Inc. - Key Financials (Million US$), 2017-2019
Table 10-16: Thermo Fisher Scientific Inc. - Product Portfolio for Point-of-Care Testing
Table 10-17: Medtronic plc - Key Financials (Billion US$), 2017-2019
Table 10-18: Medtronic plc - Product Portfolio for Point-of-Care Testing
